BSW Wealth Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,103
Closed -$241K 332
2022
Q3
$241K Buy
5,103
+183
+4% +$11.8K 0.06% 230
2022
Q2
$353K Buy
4,920
+714
+17% +$52.2K 0.08% 165
2022
Q1
$340K Buy
4,206
+529
+14% +$44.8K 0.09% 185
2021
Q4
$378K Buy
3,677
+349
+10% +$33.5K 0.09% 160
2021
Q3
$291K Buy
3,328
+494
+17% +$44.7K 0.08% 188
2021
Q2
$254K Buy
+2,834
New +$239K 0.07% 200

Other funds holding SYNH

BSW Wealth Partners's SYNH Position: Q4 2022 in Review

BSW Wealth Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 5,103 shares — an estimated $241K sold.

BSW Wealth Partners first reported a position in SYNH in Q2 2021 and held it in 6 quarters. The position peaked at $378K in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • BSW Wealth Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • BSW Wealth Partners sold 5,103 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $241K.
  • BSW Wealth Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2021 and held it in 6 quarters.
  • BSW Wealth Partners's Syneos Health, Inc. Class A Common Stock position peaked at $378K in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on BSW Wealth Partners's 13F filing for Q4 2022, filed 14 Feb 2023.